Kinesio Taping for Upper Extremity Motor Function in Acute Stroke Patients (KT-AcuteStroke)

December 17, 2025 updated by: Havvanur Albayrak, Koç University

The Effects of Kinesio Taping on the Upper Extremity Motor Function, Pain, General Health and Depression in Acute Stroke Patients: A Randomized Controlled Trial

This randomized, controlled clinical trial was conducted to evaluate the effects of kinesio taping on upper extremity motor recovery in patients with acute ischemic stroke who presented with flaccid muscle tone. Twenty-six adults were randomly assigned to either a kinesio taping group or a sham taping group, in addition to receiving standard rehabilitation. Participants were evaluated at baseline, at the end of the 3-week taping period, and at 6 weeks using validated measures of motor function, pain, general health, and depression. The study aimed to determine whether kinesio taping provides additional benefits beyond conventional rehabilitation in improving motor performance of the wrist and hand, reducing pain, and supporting overall functional and emotional well-being in the early phase of stroke recovery.

Study Overview

Detailed Description

This prospective, randomized, controlled parallel-group trial investigated the clinical effects of kinesio taping on motor recovery of the upper extremity in patients with acute ischemic stroke. Participants were adults aged 50-80 years, within the first six months after stroke, presenting with Brunnstrom Stage 1 flaccid upper extremity and hand. Individuals with hemorrhagic stroke, prior upper limb surgery, severe shoulder pain, additional neurological conditions, or musculoskeletal complications affecting the upper limb were excluded. All participants received standard rehabilitation, including positioning training, conventional exercises, and splinting as needed.

Participants were randomized (1:1) into a kinesio taping group or a sham taping group. The kinesio taping protocol followed standard facilitation techniques applied to the dorsum of the hand and forearm with appropriate tension, aiming to support finger, wrist, and hand activation. Sham taping was performed without tension and without crossing joints, to avoid therapeutic effect while maintaining participant blinding. Both groups received three taping applications over approximately three weeks.

Outcome measures included Brunnstrom staging, Fugl-Meyer Assessment (upper extremity, wrist, and hand subscales), Visual Analog Scale for hand pain, Health Assessment Questionnaire, and Beck Depression Inventory. Evaluations were performed before treatment, at the end of the 3-week intervention period, and at 6 weeks. Statistical analyses were conducted using standard non-parametric methods for intra- and inter-group comparisons.

The study was designed to determine whether kinesio taping provides additional benefit beyond conventional rehabilitation in facilitating neurophysiological recovery, improving wrist and hand motor function, reducing pain, supporting functional independence, and decreasing depressive symptoms in the acute phase of stroke. No adverse events were observed during the study.

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey (Türkiye)
        • SB Istanbul Education and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged 50-80 years
  • Diagnosis of acute ischemic stroke confirmed by CT or MRI
  • Within first 6 months after stroke onset
  • Brunnstrom Stage 1 for upper extremity and hand (flaccid muscle tone)
  • Sufficient cognitive ability to follow instructions
  • Participation in inpatient or outpatient stroke rehabilitation
  • Ability to provide informed consent

Exclusion Criteria:

  • Hemorrhagic stroke etiology
  • Prior upper extremity surgery, fracture, contracture, or heterotopic ossification
  • Brachial plexus injury or peripheral nerve lesions
  • Additional neurological disorders (e.g., Parkinson's disease, spinal cord injury, polyneuropathy)
  • Severe shoulder pain (VAS ≥ 5) that could interfere with assessments
  • Significant musculoskeletal disorders affecting the hemiplegic upper extremity
  • Uncontrolled comorbidities that prevent participation in rehabilitation
  • Inability to complete follow-up assessments

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Kinesio Taping
Participants received kinesio taping applied to the dorsum of the hand and forearm using standard facilitation techniques with approximately 25% tension, in addition to conventional rehabilitation.
Kinesio tape was applied to the dorsum of the hand with five 1-cm I-strips and one 5-cm I-strip extending toward the forearm, with ~25% stretch. Three applications over approximately 3 weeks.
Sham Comparator: Sham Taping
Participants received sham taping without tension and without crossing joints, mimicking the appearance of kinesio taping but without therapeutic effect, in addition to conventional rehabilitation.
Sham taping was performed using Y- and I-strips without stretch and without crossing joints. Three applications over approximately 3 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Fugl-Meyer Wrist, Sitting Position Upper Extremity and Hand Scores
Time Frame: Baseline, Week 3, Week 6
Fugl Meyer Rating Scale (FMRS) was used to evaluate motor function. This scale was developed to evaluate the patient's sensorimotor recovery after stroke by the Brunnstrom motor healing stages. The scale covers the upper extremity in 3 parts: the shoulder-elbow-forearm, the sitting position in the wrist, the hand; and allows the evaluation of reflex activity, synergy patterns and voluntary movements. It is a reliable method for assessing the severity of post-stroke sensorimotor impairment. The maximum total score for the upper extremity in FMRS is 66.
Baseline, Week 3, Week 6

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Brunnstrom Staging (Upper Extremity and Hand)
Time Frame: Baseline, Week 3, Week 6
Combined assessment of upper extremity and hand motor recovery using the Brunnstrom Staging system (Stages 1-6). Higher stages indicate progressive neurophysiological motor recovery in the shoulder-elbow-forearm and hand components.
Baseline, Week 3, Week 6
Change in Visual Analog Scale (VAS) for Hand Pain
Time Frame: Baseline, Week 3, Week 6
Pain intensity measured using a 10-cm visual analog scale (0 = no pain, 10 = worst pain). Lower scores indicate reduced hand pain.
Baseline, Week 3, Week 6
Change in Health Assessment Questionnaire (HAQ) Disability Index
Time Frame: Baseline, Week 3, Week 6
Health Assessment Questionnaire (HAQ) was used for the general health evaluation of the patients. HAQ evaluates the functional ability of the patient in both upper and lower extremities. There are 20 questions in eight functionalities that represent a comprehensive range of functional activities, such as dressing, uplifting, eating, walking, hygiene, access, comprehension, and regular activities. The patient's responses are made on a scale from zero (unobstructed) to three (completely disabled).
Baseline, Week 3, Week 6
Change in Beck Depression Inventory (BDI) Score
Time Frame: Baseline, Week 3, Week 6
Depressive symptoms measured by the Beck Depression Inventory (0-63). Lower scores indicate reduced depression severity.
Baseline, Week 3, Week 6

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Havvanur Albayrak, Koç University School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2018

Primary Completion (Actual)

September 1, 2018

Study Completion (Actual)

November 10, 2018

Study Registration Dates

First Submitted

November 30, 2025

First Submitted That Met QC Criteria

December 17, 2025

First Posted (Actual)

December 24, 2025

Study Record Updates

Last Update Posted (Actual)

December 24, 2025

Last Update Submitted That Met QC Criteria

December 17, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Ischemic Stroke

Clinical Trials on Kinesio Taping

Subscribe